Beaver Biology Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Beaver Biology General Information

Description

Developer of nano-magnetic bead technology and product development designed to make sample processing and tracing of biological macromolecules more efficient. The company's technology focuses on the research and development of biomedical diagnosis tools and devices using nano-magnetic bead technology, enabling physicians to improve their testing accuracy and attain efficient diagnostic result.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 36, Northeast District, Nano City
  • No. 99, Jinjihu Avenue
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Building 36, Northeast District, Nano City
  • No. 99, Jinjihu Avenue
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beaver Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 29-Jul-2022 Completed Generating Revenue
2. Later Stage VC (Series B) 21-Apr-2021 Completed Generating Revenue
1. Later Stage VC (Series A) 31-May-2017 Completed Generating Revenue
To view Beaver Biology’s complete valuation and funding history, request access »

Beaver Biology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beaver Biology Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Suzhou New Sea Union Telecom Technology Company Corporation Minority
Clivia Capital Growth/Expansion Minority
CM Venture Capital Venture Capital Minority
Jiangsu Tongren Boda Private Equity Fund Management Venture Capital Minority
Shenzhen Huihe Asset Management Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Beaver Biology Investments (1)

Beaver Biology’s most recent deal was a Corporate with Cellpro Biotechnology. The deal was made on 20-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cellpro Biotechnology 20-Jan-2019 Corporate Other Devices and Supplies
To view Beaver Biology’s complete investments history, request access »

Beaver Biology FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process